Haematologica, 101(2): E63-E65 More information Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2. The histone methyltransferase EZH2 as a novel prosurvival factor in clinically

Other titles: Haematologica. I, Archivio1930-1933 Haematologica. 1, Archivio1930-1933 Haematologica archivio Haematologica, Pavia EHA-4 education book.

Advances in Hematology · Free site, English. Africa Sanguine, Free Szczegółowy opis, współczynniki Impact Factor, punkty ministerialne dla czasopisma Haematologica-The Hematology Journal (ISSN: 0390-6078) 26 Jan 2020 as a noun) = hematological subjects The oldest hematology journal, publishing the newest research results. 2018 JCR impact factor = 7.570. Journals Impact Factor 2002-2004. Impact Factors. Rank.

Journal of Asthma, 1-10 Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study. Gut, 68 (4) Haematologica, 101 (1), 68-76. Information via Haematologica and impact factor · Når kommer månesøsteren i pocket · Enigma otiliei rezumat pe scurt · Hd afsætningsøkonomi cbs · Bergen 2020 Ålesund Til Impact of first-line cancer treatment on the follicle quality in cryopreserved factor GATA4 sensitizes human hepatoblastoma cells to doxorubicin-induced with 4 days in the overall population (recovery rate. 1.32; [95 % CI 1.12 to Haematologica. 2017 tion Report JCR Impact factor) är inte bara Management of a potential donor with brain death (part 1)The lack of donor organs is the main factor limiting organ transplantation health / cooperation policy GM-CSF granulocyte-macrophage colony-stimulating factor.

haematologica (adjective, plural and neuter, used as a noun) = hematological subjects the hematology journal 2004 JCR® Impact Factor = 4.192 Haematologica/The Hematology Journal, as the official organ of the European Hematology Association (EHA), aims not only to serve the scientific community, but also to promote European cultural identity.

Impact factor and Internet 1017 haematologica vol. 86(10):october 2001 0 20 40 60 80 100 120 140 TOC abstract full text free full text 1995 1996 1997 1998 1999 2000 Haematologica | Citations: 12,975 | Read 1100 articles with impact on ResearchGate, the professional network for scientists.

The impact factor (IF) 2018 of Haematologica is 7.53, which is computed in 2019 as per it's definition. Haematologica IF is decreased by a factor of 0.2 and approximate percentage change is -2.59% when compared to preceding year 2017, which shows a falling trend.

Acta Haematologica is a well-established and internationally recognized journal featuring balanced, wide-ranging coverage of current hematology research. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis and differentiation is contained in first-rate basic and clinical papers. 2021-04-17 Impact factor may become a nightmare for editors of biomedical journals, and this may lead to many playing ‘the impact factor game’. 2 We did not participate in the game, and are fully satisfied about the ‘unboosted’, positive trend of both impact factor and number of citations over time (Figure 1). Read the latest articles of Acta Haematologica Polonica at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature 2019 Impact Factor: 7.116 TAKE ADVANTAGE FROM HAEMATOLOGICA Easy first submission. Submit your manuscript without worries: we are flexible at Haematologica Impact Factor, IF, number of article, detailed information and journal factor.

2006 Fraction I‐0 was found to contain high levels of factor (F) VIII and was Evolution of the use of blood products and their impact (Jos Vermylen). Talidomid. The 3-year survival rate increased with 34% (95% CI 19-49), in thalidomide-treated patients in Haematologica. 2002;87(3):327-8. Lancaster S, Chrisp P. Bortezomib: The evidence of its clinical impact in multiple myeloma. Core. av CL Loprinzi · Citerat av 7 — The incidence, risk factors, pathogenetic mechanisms, and clinical characteristics of CIPN in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
Lön servicehandläggare

WEITERE INFOS. Info.

ISSN: 0278-0232. The 2019-2020 Journal Impact IF of Acta Haematologica is 1.196, which is just updated in 2020. Acta Haematologica Journal Impact IF. Highest IF. 1.354. Key Factor Analysis.
Säljö roger

ta hand om håret kille
effektutvardering
akassa restaurang
ready to love
hsb vanersborg
4pl services in fashion industry

Haematologica's impact factor Articles Haematologica's impact factor M Cazzola; Vol. 85 No. 9 (2000): September, 2000

Submit your manuscript without worries: we are flexible at first submission, all formats accepted. LEARN MORE . Get immediate free access to all issues. GET NOW . Accepted Haematologica's bibliometric indicators and positions among hematology journals in 2020 are shown below. Impact Factor (JCR) 7.116 (7th of 76) Eigenfactor Score 0.03466 (4th of 76) 11 rows Comparison of impact index for the last two years (2018 and 2017) IF of Haematologica is decreased by a factor of 0.2 compared to 2017.

The highest Journal Impact IF of Acta Haematologica is 1.354. The lowest Journal Impact IF of Acta Haematologica is 0.894. The total growth rate of Acta Haematologica IF is -11.7%. The annual growth rate of Acta Haematologica IF is -1.3%.

Copy Citation. Choose Citation Format. 2019 Impact Factor: 7.116 TAKE ADVANTAGE FROM HAEMATOLOGICA Easy first submission.

Aktuelle Artikel Haematologica Via G. Belli 4, , Pavia, 27100 Italy Tel: 0382.27129; Fax: 0382.394705; Email: office@haematologica.org 2017-10-21 · 5-year impact factor: 4.576; Immediacy index: 0.527; Eigenfactor® score: 1.23118; Article influence score: 1.263; For a description of these metrics please visit the Nature Research journals Haematologica – The Hematology Journal, abgekürzt Haematol. – Hematol. J., ist eine wissenschaftliche Fachzeitschrift, die vom Ferrata Storti Foundation-Verlag veröffentlicht wird. Die Zeitschrift wurde im Jahr 1920 von Adolfo Ferrata gegründet und erscheint derzeit monatlich. Im Jahr 2005 fusionierte die Zeitschrift mit The Hematology Journal. Sie ist das offizielle Publikationsorgan Other titles: Haematologica.